SC 13G: Mineralys Therapeutics, Inc.

AI Summary

SC 13G filing by Mineralys Therapeutics, Inc..

Risk Assessment

Risk Level: low

Filing Documents

• tm245942d2_sc13g.htm (SC 13G) — 160KB
• 0001104659-24-022655.txt ( ) — 162KB

(a) Name of issuer: Mineralys Therapeutics,

Item 1(a) Name of issuer: Mineralys Therapeutics, Inc.

(b) Address of issuer’s principal

Item 1(b) Address of issuer’s principal executive offices: 150 N. Radnor Chester Rd., Ste F200, Radnor, PA 19087 2(a) Name of person filing: 1. Adams Street 2016 Direct Venture/Growth Fund LP 2. Adams Street 2017 Direct Venture/Growth Fund LP 3. Adams Street 2018 Direct Venture/Growth Fund LP 4. Adams Street 2019 Direct Growth Equity Fund LP 5. Adams Street 2020 Direct Growth Equity Fund LP 6. Adams Street 2021 Direct Growth Equity Fund LP 8. Adams Street Growth Equity Fund VII LP 2(b) Address or principal business office or, if none, residence: For all filing persons listed in 2(a) above: One North Wacker Drive, Suite 2700, Chicago, Illinois 60606 2(c) Citizenship: 1. Adams Street 2016 Direct Venture/Growth Fund LP: Delaware 2. Adams Street 2017 Direct Venture/Growth Fund LP: Delaware 3. Adams Street 2018 Direct Venture/Growth Fund LP : Delaware 4. Adams Street 2019 Direct Growth Equity Fund LP: Delaware 5. Adams Street 2020 Direct Growth Equity Fund LP: Delaware 6. Adams Street 2021 Direct Growth Equity Fund LP: Delaware 8. Adams Street Growth Equity Fund VII LP: Delaware 2(d) Title of class of securities: Common Stock 2(e) CUSIP No.: 603170101 Item 3. If this statement is filed pursuant to §§240.13d–1(b) or 240.13d–2(b) or (c), check whether the person filing is a: NOT APPLICABLE Item 4 . Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 1. Adams Street Partners, LLC: 2,302,329 (total number of shares of common stock of issuer held indirectly through the funds listed below) 2. Adams Street 2016 Direct Venture/Growth Fund LP: 185,689 3. Adams Street 2017 Direct Venture/Growth Fund LP: 240,216 4. Adams Street 2018 Direct Venture/Growth Fund LP : 358,736 5. Adams Street 2019 Direct Growth Equity Fund LP: 201,521 6. Adams Street 2020 Di

classification of the relevant subsidiary. If a parent holding

Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d–1(c) or Rule 13d–1(d), attach an exhibit stating the identification of the relevant subsidiary. NOT APPLICABLE Item 8 . Identification and Classification of Members of the Group. If a group has filed this schedule pursuant to §240.13d–1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d–1(c) or Rule 13d–1(d), attach an exhibit stating the identity of each member of the group. Adams Street 2016 Direct Venture/Growth Fund LP (“AS 2016”) is the record owner of 185,689 shares of common stock of the Issuer. Adams Adams Street 2018 Direct Venture/Growth Fund LP (“AS 2018”) is the record owner of 358,736 shares of common stock of the Issuer. Adams Street 2019 Direct Growth Equity Fund LP (“AS 2019”) is the record owner of 201,521 shares of common stock of the Issuer. Adams Street 2020 Direct Growth Equity Fund LP (“AS 2020”) is the record owner of 214,890 shares of common stock of the Issuer. Adams Street 2021 Direct Growth Equity Fund LP (“AS 2021”) is the record owner of 208,474 shares of common stock of the Issuer. Adams Street Growth Equity Fund VII LP (“AS GE VII”) is the record owner of 892,803 shares of common stock of the Issuer. The shares of common stock owned by AS 2016, AS 2017, AS 2018, AS 2019, AS 2020, AS 2021 and AS GE VII (the “Shares”) may be deemed to be beneficially owned by Adams Street Partners, LLC, the managing member of the general partner of the general partner of each of AS 2016, AS 2017, AS 2018, AS 2019, AS 202

View Full Filing

View this SC 13G filing on SEC EDGAR